Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Zevra Therapeutics Inc (NASDAQ: ZVRA) closed at $8.29 in the last session, down -2.24% from day before closing price of $8.48. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 0.59 million shares were traded. ZVRA stock price reached its highest trading level at $8.7299 during the session, while it also had its lowest trading level at $8.17.
Ratios:
We take a closer look at ZVRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on October 07, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On September 24, 2024, Maxim Group reiterated its Buy rating and also lowered its target price recommendation from $18 to $25.
On September 24, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.JMP Securities initiated its Mkt Outperform rating on September 24, 2024, with a $17 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 11 ’24 when Watton Corey Michael bought 500 shares for $7.92 per share. The transaction valued at 3,958 led to the insider holds 1,500 shares of the business.
Clifton R. LaDuane bought 2,000 shares of ZVRA for $13,540 on Jul 17 ’24. The CFO & Treasurer now owns 18,469 shares after completing the transaction at $6.77 per share. On Jul 16 ’24, another insider, Anderson Thomas, who serves as the Director of the company, bought 10,000 shares for $6.81 each. As a result, the insider paid 68,065 and bolstered with 20,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZVRA now has a Market Capitalization of 442486208 and an Enterprise Value of 411805856. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.85 while its Price-to-Book (P/B) ratio in mrq is 6.32. Its current Enterprise Value per Revenue stands at 16.816 whereas that against EBITDA is -5.067.
Stock Price History:
Over the past 52 weeks, ZVRA has reached a high of $9.76, while it has fallen to a 52-week low of $4.20. The 50-Day Moving Average of the stock is -4.51%, while the 200-Day Moving Average is calculated to be 26.31%.
Shares Statistics:
According to the various share statistics, ZVRA traded on average about 828.79K shares per day over the past 3-months and 389910 shares per day over the past 10 days. A total of 53.23M shares are outstanding, with a floating share count of 53.08M. Insiders hold about 0.56% of the company’s shares, while institutions hold 54.55% stake in the company. Shares short for ZVRA as of 1732838400 were 4305541 with a Short Ratio of 5.19, compared to 1730332800 on 3937545. Therefore, it implies a Short% of Shares Outstanding of 4305541 and a Short% of Float of 8.09.
